학술논문

Temozolomide in the treatment of an invasive prolactinoma resistant to dopamine agonists
Document Type
Author abstract
Source
Pituitary. March, 2007, Vol. 10 Issue 1, p81, 6 p.
Subject
Temozolomide -- Physiological aspects
Language
English
ISSN
1386-341X
Abstract
Prolactinomas are common tumors of the anterior pituitary gland. While conventional therapies, including dopamine agonists, transsphenoidal surgery and radiotherapy, are usually effective in controlling tumor growth, some patients develop treatment-resistant tumors. In this report, we describe a patient with an invasive prolactinoma resistant to conventional therapy that responded to the administration of the alkylating agent, temozolomide.